BOSTON |
BOSTON (Reuters) - Massachusetts adopted
new regulations on Thursday that it said will allow it to keep a closer eye on
compounding pharmacies, a class of drug supplier linked to the U.S. meningitis
outbreak that has so far killed 29 people.
The state, home to the New England Compounding Center that produced the
injectable steroids at the heart of the outbreak, said the new rules give it the
authority to track the volume and distribution of drugs that compounding
pharmacies sell to determine if they are operating like manufacturers.Compounding pharmacies - which are meant to assemble the raw ingredients of any medication one prescription at a time, not in industrial scale runs - had prior to this year's outbreak largely escaped the U.S. Food and Drug Administration's attention.
"Together with our federal partners, we will ensure that Massachusetts fulfills its responsibility in overseeing this transforming industry," said Dr. Lauren Smith, interim commissioner of the Massachusetts Department of Public Health.
Continue reading here
No comments:
Post a Comment